RecruitingNot applicableNCT06222372
Novel Interventions and Diagnostic Tests for Leprosy
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Annemieke Geluk
- Principal Investigator
- Annemieke Geluk, PhDAcademisch Ziekenhuis Leiden (LUMC)
- Intervention
- Rifampin(drug)
- Enrollment
- 1100 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2020 – 2026
Study locations (1)
- The Leprosy Mission International - Bangladesh, Nilphamari, Bangladesh
Collaborators
The Leprosy Mission Bangladesh
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06222372 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia